Screening of the use of benzodiazepines during Covid-19 pandemic in the general population
Journal
Macedonian pharmaceutical bulletin
Date Issued
2021
Author(s)
Kacarska, Milijana
DOI
10.33320/maced.pharm.bull.2021.67.01.002
https://repository.ukim.mk/retrieve/46812/104.pdf
Abstract
Benzodiazepines have been commonly prescribed for the treatment of anxiety and insomnia in the last few decades. There has been
a rising concern regarding safety of benzodiazepines due to overdose related deaths, addictions and cognitive side effects. COVID-19
pandemic is expected to cause a mental health crisis. Several studies have shown an increase in anxiety and insomnia. Тhe prescriptions
of benzodiazepines could increase due to increase in anxiety and insomnia. The pandemic calls for a rapid adaptation of conventional
medical practices to meet the evolving needs of such vulnerable patients. COVID-19 patients may frequently require treatment with
psychotropic medications. This pandemic is leading to additional health problems such as stress, anxiety, depressive symptoms,
insomnia, denial, anger and fear, globally.
The COVID-19 pandemic is a challenge to humanity. It is not only a health crisis but also a social crisis. The life is unlikely to be
the same after we come out of the pandemic. There will be changes at the level of individuals, families, communities, states, nations,
international relationships, and the way all of us will deal with a range of human and environmental situations. Disasters are always
associated with increased rates of emotional health needs from distress to specific disorders, such as posttraumatic stress disorder. Past
experiences have shown psychosocial interventions, ranging from self‑care, psychological first aid, counseling, social support and formal
psychiatric care can minimize the emotional health impact of disasters. These activities can be initiated by individuals and professionals.
a rising concern regarding safety of benzodiazepines due to overdose related deaths, addictions and cognitive side effects. COVID-19
pandemic is expected to cause a mental health crisis. Several studies have shown an increase in anxiety and insomnia. Тhe prescriptions
of benzodiazepines could increase due to increase in anxiety and insomnia. The pandemic calls for a rapid adaptation of conventional
medical practices to meet the evolving needs of such vulnerable patients. COVID-19 patients may frequently require treatment with
psychotropic medications. This pandemic is leading to additional health problems such as stress, anxiety, depressive symptoms,
insomnia, denial, anger and fear, globally.
The COVID-19 pandemic is a challenge to humanity. It is not only a health crisis but also a social crisis. The life is unlikely to be
the same after we come out of the pandemic. There will be changes at the level of individuals, families, communities, states, nations,
international relationships, and the way all of us will deal with a range of human and environmental situations. Disasters are always
associated with increased rates of emotional health needs from distress to specific disorders, such as posttraumatic stress disorder. Past
experiences have shown psychosocial interventions, ranging from self‑care, psychological first aid, counseling, social support and formal
psychiatric care can minimize the emotional health impact of disasters. These activities can be initiated by individuals and professionals.
File(s)![Thumbnail Image]()
Loading...
Name
104.pdf
Size
445.86 KB
Format
Adobe PDF
Checksum
(MD5):7e92fc1f200d040935b2443967e24fe9